tak-676
Showing 1 - 2 of 2
Head and Neck Squamous Cell Carcinoma Trial in United States (TAK-676, Carboplatin, 5-FU)
Completed
- Head and Neck Squamous Cell Carcinoma
- TAK-676
- +8 more
-
Shreveport, Louisiana
- +3 more
Oct 3, 2023
NSCLC, Triple Negative Breast Tumors, Squamous Cell Carcinoma of Head and Neck Trial in United States (Pembrolizumab, TAK-676,
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +2 more
- Pembrolizumab
- +2 more
-
West Hollywood, California
- +5 more
Mar 17, 2022